Moldova, one of the poorest countries in Europe went through an economic and financial crisis during the 1990s, which took a serious toll on the health system. This increased the incidence of TB and HIV/AIDS, which began to approach dangerous levels, threatening the population’s health and the nation’s productivity. To support the Government of Moldova’s efforts to control these diseases, the World Bank approved financing for a development grant to the Republic of Moldova for US$5.5 million equivalent to finance the proposed AIDS Control Project. In parallel, the project carried out activities related to the control of TB under the framework of parallel financing under the GFTAM. The objective of the project was to improve Moldova’s health status through reducing mortality, morbidity and the transmission of HIV/AIDS and other sexually transmitted infections.
Results of Sanigest Engagement
Sanigest Internacional was employed to design and implement a monitoring and evaluation system to assess the project’s outputs and outcomes.
Outputs included (i) key project indicators; (ii) disbursement; (iii) monitoring targets for the implementation of each component.
Outcomes included the design of a system to monitor and evaluate the impact on (i) health status; (ii) patient and provider satisfaction; (iii) health services quality, cost effectiveness and efficiency, all related to morbidity and mortality in TB and HIV/AIDS.
In addition Sanigest completed the following:
- Collection of data on the indicators established as part of the design phase
- Validation of the indicators presented as the project’s baseline and the final report
- Coordination of the execution of qualitative research on consumer satisfaction, organizational climate, and health service quality, including the use of the TB social assessment and other pre-existing documentation
- Data processed and prepared for entry into a database for continued monitoring and evaluation of the TB/AIDS project
- Procedures developed for implementation and data collection using a TB surveillance system, providing patient level data with the following features: (a) registers all TB cases; (b) registers alternative treatment regimes, by patient; (c) registers patient activity in terms of hospitalization and outpatient visits and their duration; (d) allows assessment of treatment results; (e) monitors drug resistance; (e) tracks overall coverage and quality of the program; (f) provides quarterly report.